- Home
- Applications
- faroe islands
- kidney disease
Show results for
Refine by
Kidney Disease Product Applications Available In Faroe Islands
6 applications found
Etelcalcetide is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on hemodialysis.https://www.creative-peptides.com/product/etelcalcetide-item-10-101-140-34909.html ...
ByCreative Peptides based in New York, NEW YORK (USA)
We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. ...
ByOtsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA)
In end-stage renal disease (ESRD), the majority of the patients die not because of the renal disease but because of cardiovascular events. Consequently, the cardiovascular risk assessment is of high importance in the field of Nephrology. A large number of evidences have proved the prognostic value of the aortic Pulse Wave Velocity (PWVao) for Cardiovascular (CV) morbidity and mortality in ...
ByTensiomed based in Budapest, HUNGARY
Our flagship products, Virtue SAB and BackBeat CNT, have the potential to improve clinical outcomes and provide distinct commercial advantages within two of the largest and most well-established global medical device ...
ByOrchestra BioMed, Inc. based in New Hope, PENNSYLVANIA (USA)
Building on our expertise in cell sorting tools incorporating shadow imaging for detection and characterization of cells, we are developing medical diagnostic devices leveraging these technologies, along with microfluidic integrated biosensors, to capture and quantify cells from unprocessed whole blood or other body fluids. This healthcare platform technology addresses significant underserved clinical needs in the home and primary care settings for innovative, inexpensive, accurate and easy-to-use point-of-care ...
ByZyMōt Fertility, Inc. based in Gaithersburg, MARYLAND (USA)
The CV risk assessment and the hypertension management are ones of the most common activities by the cardiologists. The measurement of arterial stiffness provides a strong and independent marker to reveal high CV risk even among those subjects, whose traditional risk factors based CV risk scores provide normal or only intermediate risk. It is a well known fact that there is a significant difference between the anti-hypertensive drugs concerning their lowering efficacy of central blood pressure and the arterial ...
ByTensiomed based in Budapest, HUNGARY